Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Tegafur / gimeracil / oteracil

EU orphan designation number: EU/3/07/515
Active ingredient: Tegafur / gimeracil / oteracil
Indication: Treatment of gastric cancer
Sponsor: Taiho Pharma Europe Limited
c/o Wragge & Co LLP, 3 Waterhouse Square, 142 Holborn, London EC1 2SW, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/12/2007 Orphan designation EMEA/OD/073/07 (2007)6807 of 20/12/2007
10/02/2009 Transfer of orphan designation EMEA/OD/073/07/T/01 (2009)973 of 06/02/2009
26/05/2009 Transfer of orphan designation EMEA/OD/073/07/T/02 (2009)4113 of 20/05/2009
25/01/2011 Removal of orphan designation from Community Register